We have performed biochemical analyses of cdk6 complexes in T cells. By gel ®ltration chromatography we observed at least three cdk6 containing complexes in the cell, the most abundant eluting at 450 kDa and 50 ± 70 kDa and a minor complex eluting at 170 kDa. Cyclin D was present in the minor 170 kDa complex which coeluted with the peak of cdk associated in vitro Rb kinase activity. Analysis of proteins that co-immunoprecipitated with cdk6 showed that the 450 kDa complex contained both Hsp90 and CDC37. The 50 ± 70 kDa complex was made up of two moieties, a 66 kDa complex containing cdk6 bound to p19
Introduction
The commitment to undergo cell division is made late in G1 when a cell loses the requirement for extracellular stimuli and passes through the restriction point (Pardee, 1989) . Progression through the mammalian cell cycle is regulated by a number of cyclin dependent kinases (cdks) and their regulatory subunits, cyclins. (Morgan, 1995; Pines, 1995; Sherr, 1995) . Recent evidence suggests that the D-type cyclins and their catalytic partners, cdk4 and cdk6, play an important role in the integration of extracellular stimuli with respect to the cell cycle (Lukas et al., 1996; Sherr, 1995) . Dierential expression of the three D-type cyclins (D1, D2 and D3) is dependent upon cell type and induction of D-type cyclins occurs upon mitogen stimulation, with protein levels persisting throughout the cell cycle (Ajchenbaum et al., 1993; Matsushime et al., 1991) . Overexpression of cyclin D1 accelerates progression through the G1 phase of the cell cycle and reduces the requirement of the cell for mitogens (Jiang et al., 1993; Quelle et al., 1993; Resnitzky et al., 1994) . Microinjection of antibodies to cyclin D1 before the restriction point has been shown to prevent entry into S phase (Baldin et al., 1993; Quelle et al., 1993) . In addition, the INK family of inhibitors (p15
INK4b
, p16
INK4a

, p18
INK4c and p19
INK4d
) speci®cally inhibit cdk4 and cdk6 and do not interact with other cdks (Chan et al., 1995; Guan et al., 1994 Guan et al., , 1996 Hannon and Beach, 1994; Hirai et al., 1995; Serrano et al., 1993) . The INK inhibitors can block D-type cyclin kinase activity and overexpression elicits a G1 arrest. Therefore D-type cyclin kinase activity is thought to be important for passage through the restriction point.
The product of the retinoblastoma gene (Rb) is thought to be a major regulator of G1 progression and passage through the restriction point. Phosphorylation of Rb occurs during the G1 phase of the cell cycle and so inactivates the growth inhibitory eects of Rb (Weinberg, 1995) . Reconstitution of D-type cyclin/ kinase complexes in baculovirus shows that all six possible complexes are capable of phosphorylating Rb in vitro Matsushime et al., 1994; Meyerson and Harlow, 1994) . It has therefore been proposed that the major role of the D-type cyclin kinases is to phosphorylate Rb, thus blocking the ability of Rb to suppress the activity of S-phase promoting transcription factors (Nevins, 1992; Sherr, 1996) . Consistent with this model is evidence suggesting that D-type cyclin activity is not required in cells that lack functional Rb protein (Koh et al., 1995; Lukas et al., 1995a,c) . While phosphorylation of Rb may be an important role for D-type cyclin kinases, this does not preclude the possibility that there are additional potential substrates. Recent work has suggested that D-type cyclin kinases may regulate gene expression in an Rb-independent manner by direct interaction and phosphorylation of the myb-like transcription factor DMP1 (Hirai and Sherr, 1996) .
Both cyclin D1 and cdk4 have been shown to play a role in tumorigenesis (Hall and Peters, 1996) , consequently considerable eort has focused on the regulation of D-type cyclin/cdk4 complexes. In contrast, much less is known about the regulation of D-type cyclin/cdk6 complexes. Cdk6 was ®rst identi®ed as a homologue of the cdc2 kinase (Meyerson et al., 1992) and was later shown to associate with D-type cyclins (Bates et al., 1994; Meyerson and Harlow, 1994) . Cdk6 associated Rb kinase activity was detected in phytohemagglutinin-stimulated primary T cells (Meyerson and Harlow, 1994) , and it has been proposed that activation of cdk6 is an early event following T cell activation (Lucas et al., 1995) . Although it is not known if cdk6 activity is necessary for T cell proliferation, the expression of cdk6 and Dtype cyclins makes T cells a convenient system for studying the regulation of cdk6 activity. In addition, recent evidence suggests that deregulation of cdk6 activity may play a role in the onset of some tumours, since elevated cdk6 activity was detected in squamous cell carcinoma cell lines (Timmermann et al., 1997) .
In this report we describe biochemical analyses of cdk6 complexes in T cells. We demonstrate that cdk6 is associated with other proteins in addition to the D-type cyclins. Moreover, of the total cellular cdk6, only a small proportion was found associated with a D-type cyclin. Signi®cantly, this minor complex is active and accounts for the majority of the cellular kinase activity, as assayed by in vitro phosphorylation of GST-Rb. Furthermore, although cyclin D/cdk6 complexes are detectable in both the cytoplasm and nucleus, only the cdk6 that is in the nucleus is biochemically active.
Results
Identi®cation of multiple cdk6 complexes by gel ®ltration chromatography
The activation of cdk6 in T cells is an early event during the stimulation of T cell proliferation (Lucas et al., 1995; Meyerson and Harlow, 1994) . The mechanism of this activation is poorly understood and may depend upon the interaction of a number of dierent proteins controlling the formation of an active cyclin D/cdk6 complex. We therefore undertook a biochemical analysis using gel ®ltration chromatography to identify cdk6 containing complexes and their associated molecules.
Human primary T cells were prepared from donor buy coats by positive CD4/CD8 selection and were stimulated with phytohemagglutinin (PHA) for 65 h. Lysates from these activated T cells were separated by gel ®ltration chromatography using a Superdex 200 column. Fraction collection commenced at the void volume (V O ) of the column and samples from each fraction were run on SDS ± PAGE and immunoblotted with antibodies against cdk6 ( Figure 1a ). In these cell lysates cdk6 eluted as two major complexes of approximately 450 kDa and 50 kDa in size, with a third minor species at about 150 ± 170 kDa. In order to con®rm that this distribution of cdk6 complexes was not unique to primary T cells we extended our analysis to other T cell lines, selected on the basis of dierential Dtype cyclin expression. The cell lines used were CEM, a human T lymphoblastoid cell line which expresses cyclin D3, KIT225, a human IL-2 dependent cell line derived from a T cell chronic lymphocytic leukemia (Hori et al., 1987) which expresses cyclins D2 and D3, and EL4, a mouse T cell lymphoma cell line which expresses cyclins D1, D2 and D3. Extracts were prepared from asynchronously growing cultures and separated by gel ®ltration chromatography as above. Similar to the primary T cells, all three cell lines contained two major cdk6 containing complexes migrating at 450 kDa and 50 ± 70 kDa (Figure 1b) . There was also a low level of cdk6 present at approximately 150 ± 170 kDa in the KIT225 and EL4 extracts, although this could not be detected in CEM cell lysates. Therefore, in both primary T cells and T cell lines cdk6 is present in at least two dierent sized complexes.
We next analysed which of these cdk6 complexes coeluted with a D-type cyclin. The same gel ®ltration fractionations were immunoblotted with antibodies against the three D-type cyclins. It was striking to notice that neither of the two major peaks of cdk6 coeluted with the peak of the D-type cyclin complexes in both CEM and EL4 cells, and that the peak of D cyclins correlated well with the minor 150 ± 170 kDa cdk6 complex (Figure 1b) . For the KIT225 cells, the cyclin D2 had a broader elution pro®le but the cyclin D3 in these cells also peaked at 150 ± 170 kDa (Figure 1b) .
To address whether the 150 ± 170 kDa complex is indeed a cyclin D/cdk6 complex we used extracts from CEM cells. CEM cells express only cyclin D3 and so contain only one possible cyclin D/cdk6 complex. CEM cell extract was separated by gel ®ltration as before and each fraction was immunoprecipitated with cdk6 antibodies. These immunoprecipitates were then immunoblotted with both cdk6 and cyclin D3 antibodies (Figure 2a ). There was a clearly detectable cyclin D3/cdk6 complex which eluted at approximately 150 ± 170 kDa. Similar sized cyclin D/cdk6 complexes were observed for the other cell lines (data not shown). The cdk6 immunoprecipitates immunoblotted with antibodies against cdk6 show that there is a detectable amount of cdk6 coeluting with the cyclin D3. However this represents only a small fraction of the total cdk6 and therefore we conclude that only a small proportion of the total cdk6 is complexed to cyclin D3.
cdk6 kinase activity comigrates with the cyclin D/cdk6 complex
The experiments above suggest that T cell extracts contain at least three dierent sized cdk6 complexes. We next wanted to establish which of these complexes contain cdk6 kinase activity. While it has been shown that cdk6 activity may be reconstituted in Sf9 cells by coinfection of cdk6 and cyclin D1 (Meyerson and Harlow, 1994) , this result does not formally exclude the possibility that cdk6 could also be activated by interacting with other molecules. In order to assay kinase activity in vitro we used a previously described GST-Rb protein as an exogenous substrate (Meyerson and Harlow, 1994) . CEM cell lysates were separated by gel ®ltration chromatography, as before, and fractions were immunoprecipitated with cdk6 antibodies in the presence or absence of competing cognate peptide. After extensive washing these immunoprecipitates were assayed for kinase activity as described in Materials and methods. Figure  2b (i) shows that a single peak of kinase activity migrated at approximately 150 ± 170 kDa, resulting in a signi®cant change in the mobility of the GST-Rb substrate as a result of the phosphorylation. There is a background level of substrate phosphorylation in the presence of competing peptide (Figure 2b (ii)), but the shifted form of GST-Rb is a useful readout for activity. Quantitation of the shifted band shows that over 70% of the total kinase activity eluted with the single peak of kinase activity at 150 ± 170 kDa (data not shown). The remaining kinase activity represented a low background signal in each fraction and no other clear peaks of kinase activity could be observed. Therefore we conclude that the cdk6 associated kinase activity comigrates with the cdk6/cyclin D3 complex and that only a small proportion of the total amount of cdk6 in the cell is biochemically active.
Identi®cation of proteins associated with cdk6
Since only a small proportion of the total cdk6 is bound to cyclin D it was necessary to identify other cdk6 associated proteins as these interactions may be important for the regulation of the active complex. We identi®ed proteins that coimmunoprecipitated with cdk6 using two detection methods. The ®rst used immunoprecipitation from metabolically labelled cells, so that cdk6 associated proteins could be identi®ed by autoradiography, while the second method utilised silver staining of cdk6 immunoprecipitates to directly visualise associated proteins.
CEM cells were metabolically labelled with 35 Smethionine for 5 min and lysates were prepared and separated by gel ®ltration chromatography. Cdk6 immunoprecipitations were performed on each fraction, and the resulting immune complexes were separated by SDS ± PAGE and visualised by autoradiography. Figure 3a shows that labelled cdk6 eluted as three complexes in CEM cells, with a similar size to those described above using Western blot analysis. The relative levels of the three complexes appear to be dierent to that observed by Western blotting, with the larger 450 kDa complex appearing less abundant, and is probably due to each complex having a dierent rate of formation and destruction (D Mahony and E Lees, in preparation).
In addition to cdk6, a number of other polypeptides were seen to speci®cally co-immunoprecipitate. In order to con®rm the identity of some of these proteins we used V8 protease analysis. Immunoprecipitating proteins of 34 kDa and 19 kDa were cut out from the gel after SDS ± PAGE and digested with increasing concentrations of V8 protease. These proteolytic cleavage patterns were compared to similar proteolytic digestions of in vitro translation products of cyclin D3 and members of the INK family of inhibitors. In this way we were able to con®rm the identity of cdk6, cyclin D3 and the inhibitor p19
INK4d (Figure 3b ). The peak of associated cyclin D3 elutes with the cdk complex at 150 ± 170 kDa ( Figure  3a) , con®rming the Western blotting results presented above. The p19
INK4d associated wtih cdk6 elutes at around 66 kDa (Figure 3a) , consistent with the size of a kinase/inhibitor dimer. However there is a peak of labelled cdk6 eluting with an apparent molecular weight of less than 66 kDa, suggesting that this may be monomeric kinase. Therefore, the previously identi®ed peak at 50 ± 70 kDa may comprise two moieties, a kinase/inhibitor dimer and free kinase.
In order to identify other proteins associated with cdk6, extracts prepared from EL4 cells were separated by gel ®ltration chromatography and fractions immunoprecipitated with antibodies against cdk6. These immunoprecipitates were separated on SDS ± PAGE and proteins were visualised by silver staining. Cdk6 eluted from the column with a similar pro®le to that previously shown by Western blotting (Figure 4a ). Two proteins of approximately 90 kDa, which coeluted with the 450 kDa cdk6 complex, were prominent and could be completely blocked by including the blocking peptide in the immunoprecipitation (data not shown). A similar 90 kDa band could also be seen in the metabolically labelled CEM cells (Figure 3a) . In order to identify these interacting proteins, lysate was prepared from 1610 9 EL4 cells, immunoprecipitated with cdk6 antisera and immune complexes collected on protein A sepharose beads. The beads were washed extensively, run on SDS ± PAGE and copper stained to visualise the 90 kDa bands which were excised from the gel. Peptide sequence was obtained for these 90 kDa proteins and database analysis of the two Immunocomplexes were assayed for Rb kinase activity sequences (EINPDHSIIETL) and (TLVDTGTGMTK) indicated that these were identical to isoforms of mouse HSP90, HSP90alpha and HSP90beta. In addition to the 90 kDa doublet, we detected a 50 kDa band comigrating with the cdk6 450 kDa complex in both silver stain and labelling experiments. Previous work has suggested that cdk4 is able to form a complex with HSP90 and CDC37, a 50 kDa protein (Dai et al., 1996; Stepanova et al., 1996) . To con®rm the presence of CDC37 in the cdk6 complex, antibodies raised to a C-terminal peptide sequence of CDC37 were used to immunoblot cdk6 immunopreci- S cell labelling mix for 5 min and lysates separated by gel ®ltration chromatography. Each fraction was immunoprecipitated with antibodies against cdk6 and immunocomplexes separated by SDS ± PAGE. The elution pro®le of molecular weight standards is shown. (b) V8 protease analysis of proteins immunoprecipitated by antibodies against cdk6. Cdk6 immunoprecipitates were separated by SDS ± PAGE and protein bands corresponding to p38, p33 and p19 were excised. These were then digested with V8 protease, analysed by 15% SDS ± PAGE and compared to digests of in vitro translates of cdk6, cyclin D3 and p19
INK4D
Biochemical analysis of cdk6 complexes D Mahony et al pitates from fractionated CEM lysates. Figure 4b shows that the cdk6 associated CDC37 comigrates with the 450 kDa cdk6 complex. Therefore this analysis suggests that the 450 kDa cdk6 complex contains HSP90, CDC37 and cdk6.
Cdk6 kinase activity is found predominantly in the nuclear extracts of CEM cells
To further characterise cdk6 complexes we investigated their subcellular distribution. Localisation of dierent complexes is likely to play a role in the formation and activation of cyclin D/cdk6. In addition little is known about the subcellular localisation of cyclin D/cdk6 activity. Since Rb phosphorylation is thought to take place in the nucleus we addressed the question of whether kinase activity is present only in the nuclear compartment.
Nuclear and cytoplasmic extracts were prepared from equivalent numbers of CEM cells. After lysing cells by dounce homogenisation, nuclei were collected by ultracentrifugation through a sucrose cushion so that they were free of contaminating membranes and cytoplasmic components. Cytoplasmic extracts were assayed for nuclei contamination by trypan blue staining to check that more than 95% of the nuclei had been removed during preparation. Both nuclear and cytoplasmic extracts were separated by gel ®ltration chromatography as before and fractions were immunoprecipitated with antibodies against cdk6. These immunoprecipitates were separated on SDS ± PAGE and then immunoblotted with anti-cdk6 antibodies. Signi®cantly, CEM nuclear extract did not contain a 450 kDa cdk6 complex (Figure 5a ). However, there are two major cdk6 complexes in the cytoplasmic extracts (Figure 5a ) distributed similarly to those seen in whole cell extracts. These data suggest that the Hsp90/CDC37/cdk6 complex is predominantly cytoplasmic and absent from the nucleus. We next sought to establish whether cyclin D3/cdk6 complexes are detectable in both nuclear and cytoplasmic fractions. Cdk6 immunoprecipitations were performed on equivalent amounts of nuclear and cytoplasmic extracts. These immunoprecipitates were separated by SDS ± PAGE and immunoblotted with antibodies against cyclin D3. Cyclin D3 is present in both the nucleus and the cytoplasm, and cyclin D3/cdk6 complexes are detectable in both compartments of the cell (Figure 5b ). Parallel immunoprecipitations from the same extracts were then used for in vitro kinase assays against the GSTRb substrate. Under these conditions hyperphosphorylation of the GST-Rb protein was observed only with nuclear cdk6 complexes. To con®rm that this activity was similar to that seen in whole extracts, nuclear extract was separated by gel ®ltration chromatography and each fraction was assayed for cdk6 associated kinase activity. The activity migrated at 150 ± 170 kDa, with an elution volume comparable to that seen for whole extracts (Figure 5d ). We conclude that only a proportion of the cdk6/cyclin D3 complexes are present in the nucleus. In addition all of the cdk6 associated kinase activity is associated with the nuclear cdk6/cyclin D3 complexes. 
Discussion
In this study we have conducted a biochemical characterisation of cdk6 containing complexes in proliferating T cells. By separating cdk6 containing complexes on the basis of size we have demonstrated that cdk6 exists in two major complexes. Surprisingly, neither of these major cdk6 complexes appears to contain a D-type cyclin. A third cdk6 complex, associated with cyclin D, elutes at approximately 150 ± 170 kDa, and this complex represents only a minority of the cdk6 in the cell. An initial analysis of cell lines other than T cells suggests that the existence of similar 450 kDa and 50 ± 70 kDa cdk6 complexes is common for many cells that express cdk6 (data not shown). In addition, elution of cdk6 activity correlates with the 150 ± 170 kDa cyclin D3/cdk6 complex in CEM cells suggesting that only a small amount of the total cdk6 in the cell is active. The amount of cdk6 in the 150 ± 170 kDa complex detectable by direct Western blotting with cdk6 antibodies appears to depend on the abundance of D-type cyclins within the cell. This qualitative observation suggests that the levels of D cyclin may be a limiting factor for the assembly of cyclin D/cdk6 complexes. However, it has been shown that overexpression of a D-type cyclin is not sucient for formation of D-type cyclin/cdk complexes, strongly suggesting that formation of this complex is a regulated step (Matsushime et al., 1994) . Cyclin D1 protein is overexpressed in many tumours, even in the absence of ampli®cation or translocation of the cyclin D1 locus (reviewed in Hall and Peters (1996) ). If formation of active complexes is a multi-step process, overexpression of cyclin D1 may disrupt the equilibrium in favour of formation of more active kinase complexes and so play a role in the onset of tumorigenesis.
The constituents of the most abundant cdk6 containing complexes were isolated by identifying proteins that coimmunoprecipitated with cdk6. A p19
INK4d /cdk6 complex eluted at approximately 66 kDa, close to the predicted molecular weight for such a dimer. This complex eluted at a slightly larger size than the peak of cdk6, suggesting that there may be monomeric cdk6 in the cell. Therefore the 50 ± 70 kDa complex appears to comprise two moieties, a p19
INK4d /cdk6 complex and free cdk6 kinase. The 450 kDa cdk6 complex was shown to contain both Hsp90 and CDC37. Such interactions are similar to those previously described interaction cdk4 (Dai et al., 1996; Stepanaova et al., 1996) . It has been proposed that cdk4 is unstable as a monomer and requires association with Hsp90/CDC37 for stabilisation (Stepanova et al., 1996) . Consequently, the Hsp90/ CDC37 complex may act as a chaperone for newly synthesised kinase, and this interaction may be a general phenomenon for a number of other kinases, including raf-1 and c-src (Schulte et al., 1995; Whitesell et al., 1994) . Analysis of cdk4 complexes in a variety of cell types by glycerol gradient centrifugation and gel ®ltration chromatography suggests that there is no detectable monomeric cdk4 in cells (Dai et al., 1996; Stepanova et al., 1996 and our unpublished observations) . While monomeric cdk4 may be very unstable, our results suggest that cdk6 can exist as a monomer in the cell. In addition, we have investigated the stability of the dierent complexes by pulse-chase labelling experiments, and observed that the 50 ± 70 kDa cdk6 complex is the most stable (D Mahony and E Lees, in preparation). Taken together, these data suggest that the regulation of cdk4 and cdk6 may be dierent, although further biochemical analysis of cdk4 complexes is required to con®rm this.
The investigation of the subcellular localisation of the dierent cdk6 complexes shows that the Hsp90/ CDC37/cdk6 is a cytoplasmic complex. This observation is consistent with immuno¯uorescence data showing that CDC37 staining was prominent in the cytoplasm of NIH3T3 cells (Stepanova et al., 1996) . Additional work, also based on immuno¯uorescence data, has shown that cyclins D1, D2 and D3 are nuclear proteins (Baldin et al., 1993; Bartkova et al., 1996; Lukas et al., 1995b) . We show here that in CEM cells cyclin D3/cdk6 complexes are detectable in both the nucleus and the cytoplasm. However, only the nuclear cyclin D3/cdk6 complex displays kinase activity. Since Rb is a nuclear protein, this nuclear activity is consistent for the proposed function of cdk6 as a Rb kinase. Moreover, this observation suggests that assembly of cyclin D/cdk6 complexes is not sucient for activation of cdk6. Further analysis is required to investigate the dierence between active nuclear complexes and inactive cytoplasmic complexes, and how this transition is regulated.
Materials and methods
Cell culture
CEM cells were obtained from ATCC (American Type Culture Collection) and were maintained in RPMI 1640 medium with 10% fetal calf serum, EL-4 cells were obtained from ATCC and were maintained in DMEM with 10% fetal calf serum, Kit 225 cells, a gift from ReneÂ de Waal Malefyt, were maintained in RPMI 1640 medium with 10% fetal calf serum and 100 U/ml recombinant human IL-2. Cells were maintained at a density of less than 8610 5 cells/ml. Peripheral blood T cells were isolated from blood packs by positive selection using CD4 and CD8 Dynal beads according to the manufacturer's instructions. Isolated CD4 and CD8 T cells were maintained in Yssel's medium (Yssel et al., 1984) and were stimulated with PHA (1 mg/ml) for 65 h.
Antibodies
Rabbit polyclonal sera were raised against peptides coupled to keyhole limpet hemacyanin for the following molecules: cdk6 (CSQNTSELNTA), cyclin D1 (CLACT-PTDVRDVDI), cyclin D2 (CDPDQATTPTDVRDVDL) cyclin D3 (CGPSQTSTPTDVTAIHL) and CDC37 (CGP-GDPLLEAVPK). Western blotting of cdk6 was performed using a previously described anti-cdk6 rabbit anti-sera (Meyerson and Harlow, 1994) . Monoclonal antibodies against Cyclin D3 (DCS22, Neomarkers) were also used for Western analysis. All peptide antisera were anity puri®ed using the antigenic peptide coupled to Sulfolink Coupling beads (Pierce) as directed by the manufacturer.
Cell lysate preparation and immunoblotting
Cells were washed once in PBS and then lysed in Tween lysis buer (50 mM HEPES pH 7.5, 10 mM MgCl 2 , 0.1% Tween-20, 1 mM DDT, 25 mM ATP, 5 mg/ml aprotinin, 5 mg/ml leupeptin, 5 mg/ml pepstatin, 5 mg/ml pefabloc) at 48C for 30 min then frozen on dry ice and thawed rapidly at 308C. Lysates were then clari®ed by centrifugation at 15 000 g for 15 min. For Western blotting analysis samples were run on SDS ± PAGE and blotted onto Immobilon-Pmembrane (Millipore). Immunodetection was performed by enhanced chemiluminescence (ECL, Amersham).
Metabolic labelling and immunoprecipitation
For metabolic labelling studies, 3610 7 CEM cells were washed with PBS and then incubated in methionine minus RPMI 1640 medium for 30 min at 378C. Cells were labelled for 5 min with 2.5 mCi radiolabelled 35 -S cell labelling mix (Amersham) in 5 ml of fresh media. Cells were lysed in Tween lysis buer as described above. Immunoprecipitations were performed by incubating lysates with 1 mg of anity puri®ed antibody for 1 h at 48C followed by addition of 50 ml of a 50% slurry of protein A sepharose beads (Pharmacia) and a further incubation for 30 min at 48C. Immunocomplexes were washed with lysis buer and then separated on SDS ± PAGE. For immunoprecipitation from radiolabelled lysates, proteins were visualised bȳ uorography using Amplify (Amersham). In order to block antibodies with competing peptide, 5 mg of peptide was preincubated with 1 mg of antibody at 308C for 30 min before beginning the immunoprecipitations.
Kinase assays
Kinase assays were carried out using an adaptation of a previously described protocol (Matsushime et al., 1994) using a GST-Rb-C terminal construct as substrate. The GST-Rb substrate was prepared as previously described (Meyerson and Harlow, 1994) , with the induced bacteria lysed with Tween lysis buer and the puri®ed GST-Rb protein dialysed overnight against kinase buer at 48C. Cells were lysed in Tween lysis buer and immunoprecipitated as described above. Immunocomplexes were washed three times with Tween lysis buer and then twice with kinase reaction buer (50 mM HEPES pH 8.0, 10 mM MgCl 2 , 2.5 mM EGTA, 1 mM DTT, 50 mM ATP). 2.5 mg of GST-Rb and 10 mCi [g-32 P]ATP were added to each sample and the volume made up to 50 ml with kinase buer. Reactions were incubated at 308C for 20 min and then stopped by the addition of 66SDS sample buer. Phosphorylated products were resolved on a 9% SDSpolyacrylamide gel and analysed by autoradiography at room temperature. Quantitation of phosphorylated bands was carried out using a Molecular Dynamics Phosphor imager (Molecular Dynamics) and Imagequant software.
Proteolytic mapping with V8 protease
Cells were radiolabelled for immunoprecipitation as above, except 5 mCi of 35 S cell labelling mix was used to label 3610 7 cells in 5 ml media. Samples were immunoprecipitated, separated by SDS ± PAGE and then dried with no ®xation. Mapping with the V8 protease from Staphylococcus aureus (Boehringer Mannheim) was performed as described previously (Cleveland et al., 1977) . A human p19 cDNA (Chan et al., 1995) was subcloned into pBluescript (Stratagene) in order to synthesise in vitro translated protein. The cDNAs for cdk6 and cyclin D3 have been previously described (Meyerson and Harlow, 1994) . In vitro translation was performed using the Promega TNT system.
Gel ®ltration chromatography
Gel ®ltration chromatography was carried out using a Superdex 200 HR 10/30 column with an FPLC system (Pharmacia). Samples (500 ml) were loaded onto the column and separated in gel ®ltration buer (50 mM HEPES pH 7.5, 10 mM MgCl 2 ) at a¯ow rate of 0.3 ml/min for the ®rst 5 ml, 0.4 ml/min for the next 10 ml and then 0.5 ml/min for the ®nal 10 ml. The molecular mass standards (Sigma) used to calibrate the column were: Blue Dextran (2000 kDa), Thyroglobulin (669 kDa), Apoferritin (443 kDa), b-Amylase (200 kDa), Alcohol Dehydrogenase (150 kDa), Bovine Serum Albumin (66 kDa), Carbonic Anhydrase (29 kDa) and Cytochrome c (12.4 kDa). The void volume of dierent columns was between 8 and 8.5 ml, and this volume was the point at which fraction collection commenced. For each fractionation twenty-four 0.5 ml fractions were collected. 70 ml of each fraction was taken for immunoblot analysis and 425 ml from each fraction was used in immunoprecipitation experiments.
Silver staining and copper staining of gels for peptide microsequencing
Immunoprecipitates were separated on SDS ± PAGE and then silver stained with the Silver Xpress silver staining kit according to the manufacturer's instructions (Novex). For isolation of proteins for microsequencing, lysates from 1610 9 EL4 cells were immunoprecipitated with cdk6 antibodies and separated on SDS ± PAGE. Bands were visualised by copper staining according to the manufacturer's instructions (BIORAD) and bands of interest excised from the gel. Peptide sequencing was performed by the Harvard Microchemistry Unit. The peptide sequences (EINPDHSIIETL) and (TLVDTGTGMTK) displayed identity to murine Hsp90 alpha and Hsp90 beta respectively.
Subcellular fractionations
Nuclei were prepared by sucrose gradient centrifugation. Brie¯y, cells were washed with PBS then resuspended in 4 ml of ice cold sucrose buer A (0.32 M sucrose, 3 mM Calcium chloride, 2 mM Magnesium acetate, 0.1 mM EDTA, 1 mM DTT, 0.1% Tween20 and 10 mM Tris pH 8.0). Cells were transferred to a Dounce homogeniser and cells broken with 50 strokes. The ruptured cells were mixed with 4 ml of ice cold sucrose buer B (2 M sucrose, 5 mM magnesium acetate, 0.1 mM EDTA, 1 mM DTT and 10 mM Tris pH 8.0) and this suspension was layered onto a 4.4 ml cushion of sucrose buer B. The gradient was spun at 300 000 g for 45 min at 48C, and the supernatant removed by vacuum aspiration. All nuclei were lysed immediately with nuclei lysis buer. Cytoplasmic extracts were prepared using an adaptation of a previously described protocol (Zha et al., 1996) . Brie¯y, cells were washed with PBS then resuspended in cytoplasmic buer A (10 mM Tris pH 7.5, 25 mM sodium¯uoride, 5 mM magnesium chloride, 1 mM EGTA, 1 mM DTT, 5 mg/ml aprotinin, 5 mg/ml leupeptin, 5 mg/ml pepstatin, 5 mg/ml pefabloc). Cells were left to swell on ice for 15 min, and then transferred to a Dounce homogeniser and ruptured with 15 to 20 strokes. Nuclei were removed from the suspension by centrifuging at 500 g for 10 min at 408C. The supernatant was removed and centrifuged at 315 000 g for 30 min at 48C.
